Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now shows a new revision label Revision: v3.5.4, replacing the prior Revision: v3.5.3. This indicates a minor update to the page's metadata or presentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:14.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s revision/version footer was updated from **v3.5.2** to **v3.5.3**, reflecting a site build or documentation update rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:56.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:08.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.5.0 released, replacing v3.4.3. This update updates the site version and UI without altering study details.
    Difference
    0.1%
    Check dated 2026-03-19T06:19:45.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is displayed, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:24:06.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2. Older notices including v3.4.1 and the government funding status notice were removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:19:11.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.